Article
Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group.
Cytokines, cellular & molecular therapy - 1 Dec 1999
Keeffe E B, Dusheiko G M, James S P, Mullen K D, Everson G T, Pimstone N R, Donovan J, Albert D
Abstract excerpt
Hepatitis C virus (HCV) genotyping has been shown to predict response to interferon, but is expensive. HCV serotyping is less expensive and simpler, and may be similarly useful. Using data from a large, randomized trial comparing consensus interferon (CIFN) and interferon alfa-2b (IFN alfa-2b) in patients with chronic HCV, we evaluated response rates based on HCV serotypes versus genotypes. Patients included in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
